Feb 24, 2020 - The approval should help the big pharmaceutical fight off competition from other drugs in the same class.
Feb 14, 2020 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.
Feb 14, 2020 - AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
Feb 12, 2020 - The drug moves closer to an expanded approval for the skin disorder.
Feb 11, 2020 - Eli Lilly's (LLY) Alzheimer's disease drug, solanezumab, fails to meet primary endpoint in a phase II/III investigator-led study.
Feb 07, 2020 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q4 sales.
Feb 06, 2020 - Sanofi (SNY) reports mixed fourth-quarter results with strong Specialty Care and Vaccines sales but soft Consumer Healthcare sales
Feb 05, 2020 - Top Research Reports for Netflix, Eli Lilly & United Parcel Service
Feb 04, 2020 - Teva (TEVA) posts positive results from two phase II/III studies on Ajovy for treating patients with chronic and episodic migraine in Japan.
Feb 03, 2020 - Check out these three dividend-paying stocks that investors might want to buy to help combat coronavirus-based market pullback fears...